Literature DB >> 25566402

Clinical importance and epidemiology of quinolone resistance.

Eu Suk Kim1, David C Hooper2.   

Abstract

The quinolone class of antimicrobial agents is one of most widely used classes of antimicrobial agents in outpatient and inpatient treatment. However, quinolone resistance in gram-positive and gram-negative bacteria has emerged and increased globally. This resistance limits the usefulness of quinolones in clinical practice. The review summarizes mechanisms of quinolone resistance and its epidemiology and implications in the most common clinical settings, urinary tract infections, respiratory tract infections, intraabdominal infections, skin and skin structure infections, and sexually transmitted diseases.

Entities:  

Keywords:  Clinical implications; Drug resistance; Epidemiology; Mechanism; Quinolones

Year:  2014        PMID: 25566402      PMCID: PMC4285002          DOI: 10.3947/ic.2014.46.4.226

Source DB:  PubMed          Journal:  Infect Chemother        ISSN: 1598-8112


  116 in total

1.  Mutation in the DNA gyrase A Gene of Escherichia coli that expands the quinolone resistance-determining region.

Authors:  S M Friedman; T Lu; K Drlica
Journal:  Antimicrob Agents Chemother       Date:  2001-08       Impact factor: 5.191

Review 2.  Efflux-mediated antimicrobial resistance.

Authors:  Keith Poole
Journal:  J Antimicrob Chemother       Date:  2005-05-24       Impact factor: 5.790

3.  Interaction between DNA gyrase and quinolones: effects of alanine mutations at GyrA subunit residues Ser(83) and Asp(87).

Authors:  F M Barnard; A Maxwell
Journal:  Antimicrob Agents Chemother       Date:  2001-07       Impact factor: 5.191

4.  Incidence and antimicrobial susceptibility of Escherichia coli and Klebsiella pneumoniae with extended-spectrum beta-lactamases in community- and hospital-associated intra-abdominal infections in Europe: results of the 2008 Study for Monitoring Antimicrobial Resistance Trends (SMART).

Authors:  Stephen P Hawser; Samuel K Bouchillon; Daryl J Hoban; Robert E Badal; Rafael Cantón; Fernando Baquero
Journal:  Antimicrob Agents Chemother       Date:  2010-04-26       Impact factor: 5.191

5.  In vitro susceptibilities of Escherichia coli isolated from patients with intra-abdominal infections worldwide in 2002-2004: results from SMART (Study for Monitoring Antimicrobial Resistance Trends).

Authors:  Grant V Bochicchio; Fernando Baquero; Po-Ren Hsueh; David L Paterson; Flávia Rossi; Theresa A Snyder; Kathleen McCarroll; Vilas Satishchandran; Mark J Dinubile; Joseph W Chow
Journal:  Surg Infect (Larchmt)       Date:  2006-12       Impact factor: 2.150

6.  Antimicrobial resistance patterns and corresponding multilocus sequence types of the Campylobacter jejuni isolates from human diarrheal samples.

Authors:  Eunju Shin; Younghee Oh; Moosang Kim; Jihun Jung; Yeonhee Lee
Journal:  Microb Drug Resist       Date:  2012-10-25       Impact factor: 3.431

Review 7.  Plasmid-mediated quinolone resistance: a multifaceted threat.

Authors:  Jacob Strahilevitz; George A Jacoby; David C Hooper; Ari Robicsek
Journal:  Clin Microbiol Rev       Date:  2009-10       Impact factor: 26.132

8.  Risk factors for community-acquired urinary tract infection due to quinolone-resistant E. coli.

Authors:  R Colodner; I Kometiani; B Chazan; R Raz
Journal:  Infection       Date:  2008-01-12       Impact factor: 3.553

9.  Prevalence and risk factors for selection of quinolone-resistant Escherichia coli strains in fecal flora of patients receiving quinolone therapy.

Authors:  D Yagci; F Yoruk; A Azap; O Memikoglu
Journal:  Antimicrob Agents Chemother       Date:  2008-12-08       Impact factor: 5.191

10.  qnrD, a novel gene conferring transferable quinolone resistance in Salmonella enterica serovar Kentucky and Bovismorbificans strains of human origin.

Authors:  L M Cavaco; H Hasman; S Xia; F M Aarestrup
Journal:  Antimicrob Agents Chemother       Date:  2008-11-24       Impact factor: 5.191

View more
  25 in total

1.  Pharmacodynamics of Tebipenem: New Options for Oral Treatment of Multidrug-Resistant Gram-Negative Infections.

Authors:  Laura McEntee; Adam Johnson; Nicola Farrington; Jennifer Unsworth; Aaron Dane; Akash Jain; Nicole Cotroneo; Ian Critchley; David Melnick; Thomas Parr; Paul G Ambrose; Shampa Das; William Hope
Journal:  Antimicrob Agents Chemother       Date:  2019-07-25       Impact factor: 5.191

2.  Persistent Pandemic Lineages of Uropathogenic Escherichia coli in a College Community from 1999 to 2017.

Authors:  Reina Yamaji; Julia Rubin; Erika Thys; Cindy R Friedman; Lee W Riley
Journal:  J Clin Microbiol       Date:  2018-03-26       Impact factor: 5.948

3.  CIPROFLOXACIN RESISTANCE PATTERN AMONG BACTERIA ISOLATED FROM PATIENTS WITH COMMUNITY-ACQUIRED URINARY TRACT INFECTION.

Authors:  Ana Carolina Costa Reis; Susana Regia da Silva Santos; Siane Campos de Souza; Milena Góes Saldanha; Thassila Nogueira Pitanga; Ricardo Riccio Oliveira
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2016-07-11       Impact factor: 1.846

4.  Pharmacokinetic-Pharmacodynamic Evaluation of Gepotidacin against Gram-Positive Organisms Using Data from Murine Infection Models.

Authors:  Catharine C Bulik; Ólanrewaju O Okusanya; Elizabeth A Lakota; Alan Forrest; Sujata M Bhavnani; Jennifer L Hoover; David R Andes; Paul G Ambrose
Journal:  Antimicrob Agents Chemother       Date:  2017-01-24       Impact factor: 5.191

5.  Molecular Characterization of qnrVC Genes and Their Novel Alleles in Vibrio spp. Isolated from Food Products in China.

Authors:  Yanyan Zhang; Zhiwei Zheng; Edward Wai-Chi Chan; Ning Dong; Xiaodong Xia; Sheng Chen
Journal:  Antimicrob Agents Chemother       Date:  2018-06-26       Impact factor: 5.191

Review 6.  Mechanisms of drug resistance: quinolone resistance.

Authors:  David C Hooper; George A Jacoby
Journal:  Ann N Y Acad Sci       Date:  2015-07-17       Impact factor: 5.691

7.  Antibiotic Use before, during, and after Seeking Care for Acute Febrile Illness at a Hospital Outpatient Department: A Cross-Sectional Study from Rural India.

Authors:  Bronwen Holloway; Harshitha Chandrasekar; Manju Purohit; Ashish Sharma; Aditya Mathur; Ashish Kc; Leticia Fernandez-Carballo; Sabine Dittrich; Helena Hildenwall; Anna Bergström
Journal:  Antibiotics (Basel)       Date:  2022-04-25

8.  Genomic Analysis of the Evolution of Fluoroquinolone Resistance in Mycobacterium tuberculosis Prior to Tuberculosis Diagnosis.

Authors:  Danfeng Zhang; James E Gomez; Jung-Yien Chien; Nathan Haseley; Christopher A Desjardins; Ashlee M Earl; Po-Ren Hsueh; Deborah T Hung
Journal:  Antimicrob Agents Chemother       Date:  2016-10-21       Impact factor: 5.191

Review 9.  Topoisomerase Inhibitors: Fluoroquinolone Mechanisms of Action and Resistance.

Authors:  David C Hooper; George A Jacoby
Journal:  Cold Spring Harb Perspect Med       Date:  2016-09-01       Impact factor: 6.915

10.  High Prevalence of Extended-Spectrum Beta-Lactamases in Escherichia coli Strains Collected From Strictly Defined Community-Acquired Urinary Tract Infections in Adults in China: A Multicenter Prospective Clinical Microbiological and Molecular Study.

Authors:  Peiyao Jia; Ying Zhu; Xue Li; Timothy Kudinha; Yang Yang; Ge Zhang; Jingjia Zhang; Yingchun Xu; Qiwen Yang
Journal:  Front Microbiol       Date:  2021-07-07       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.